"60687-706-32" National Drug Code (NDC)

Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate 20 BLISTER PACK in 1 CARTON (60687-706-32) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-706-33)
(American Health Packaging)

NDC Code60687-706-32
Package Description20 BLISTER PACK in 1 CARTON (60687-706-32) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-706-33)
Product NDC60687-706
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameEfavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate
Non-Proprietary NameEfavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate
Dosage FormTABLET, FILM COATED
UsageORAL
Start Marketing Date20221220
Marketing Category NameANDA
Application NumberANDA203053
ManufacturerAmerican Health Packaging
Substance NameEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Strength600; 200; 300
Strength Unitmg/1; mg/1; mg/1
Pharmacy ClassesCytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/60687-706-32